Kiora Pharmaceuticals (KPRX) Misses Q3 EPS by 81c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/6/2026
- Nasdaq notches record high close as investors focus on earnings
- Oil slips on rising Mideast crude exports, G7 stocks release
- Intel stock slides as TSMC explores Terafab tie-up, analyst flags share losses
- Schneider Electric to acquire PTC for $22.6 billion in all-cash deal
- Five things to watch in markets in the week ahead
Tweet
Share
E-mailGet Alerts KPRX Hot Sheet
Join SI Premium – FREE
Kiora Pharmaceuticals (NASDAQ: KPRX) reported Q3 EPS of ($0.81).
For earnings history and earnings-related data on Kiora Pharmaceuticals (KPRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Netflix (NFLX) PT Lowered to $90 at Goldman Sachs
- iRhythm Technologies (IRTC) PT Lowered to $150 at Wells Fargo
- Sphere Entertainment (SPHR) Reiterated at Market Outperform by Citizens - 'Recent Weakness an Attractive Opportunity'
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
